CDR2 and paraneoplastic neurologic syndrome: Intracellular neuronal antigens, i.e., Hu, Ri, Yo and Ma2, are known to be targeted by autoantibodies in paraneoplastic neurological syndromes (PNSs) and these autoantibodies serve as valuable biomarkers indicating the presence of underlying tumors [13].